Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Director Huda Zoghbi of Regeneron Pharmaceuticals, Inc. proposed to sell 7,439 shares of common stock with an aggregate market value of $7,219,262.83 through UBS Financial Services Inc. The shares are to be sold on or about November 3, 2026, following a stock option exercise on the same date.
Key facts
- Seller
- Huda Zoghbi
- Relationship
- Director
- Shares to sell
- 7,439
- Market value
- $7,219,262.83
- Approximate sale date
- Nov 3, 2026
- Broker
- UBS Financial Services Inc
- Acquired
- Nov 3, 2026 · stock option exercise
More REGN filings
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 144
Filed Nov 2, 2026
- 144
Filed Nov 2, 2026
- 144
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.